Real-time enrollment status for this myeloproliferative neoplasms clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:19 AM UTC
| NCT Number | NCT06661915 |
| Recruiting Status | Recruiting |
| Condition | Myeloproliferative Neoplasms |
| Phase | Clinical Trial |
| Target Enrollment | 62 participants |
| Active Locations | 6 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | February 19, 2026 (1 week ago) |
As of March 2, 2026: Clinical trial NCT06661915 is currently recruiting participants. This clinical trial study for myeloproliferative neoplasms is actively seeking new participants at 6 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06661915 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06661915 was last updated 1 week ago (February 19, 2026). HelloStudys verifies this status automatically.